Statement of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Jun. 30, 2017	$ 217	$ 3,165	$ 95,447,251	$ (75,128,691)	$ 20,321,942
Balance (in shares) at Jun. 30, 2017	217,443	3,165,342
Series A Preferred stock issued for employee stock compensation	$ 3		524,255		524,258
Series A Preferred stock issued for employee stock compensation (in shares)	2,888
Series A Preferred stock forfeited in Separation Agreement	$ (1)		1
Series A Preferred stock forfeited in Separation Agreement (in shares)	(1,250)
Series A Preferred stock issued for Series C debenture	$ 8		314,335		314,343
Series A Preferred stock issued for Series C debenture (in shares)	7,500
Common stock issued for consulting and legal services rendered		$ 12	156,178		156,190
Common stock issued for consulting and legal services rendered (in shares)		12,188
Warrants issued to Scientific Advisory Board			16,770		16,770
Warrants issued as severance payment			53,500		53,500
Common stock issued for employee compensation		$ 4	65,712		65,716
Common stock issued for employee compensation (in shares)		3,572
Common stock issued for Series C debenture		$ 275	4,729,725		4,730,000
Common stock issued for Series C debenture (in shares)		275,000
Common shares issued for Directors fees	$ 0	$ 2	44,998	0	45,000
Common shares issued for Directors fees (in shares)	0	2,489
Net loss	$ 0	$ 0	0	(8,563,455)	(8,563,455)
Balance at Jun. 30, 2018	$ 227	$ 3,459	101,352,724	(83,692,146)	17,664,264
Balance (in shares) at Jun. 30, 2018	226,581	3,458,591
Series A Preferred stock issued for employee stock compensation	$ 29		237,839		237,868
Series A Preferred stock issued for employee stock compensation (in shares)	29,133
Net proceeds from issuance of common stock in connection with equity financings		$ 347	822,394		822,741
Net proceeds from issuance of common stock in connection with equity financings (in shares)		347,223
Options issued for employee compensation			11,920		11,920
Common stock issued for consulting and legal services rendered		$ 28	208,932		208,960
Common stock issued for consulting and legal services rendered (in shares)		28,210
Warrants issued to Scientific Advisory Board			5,475		5,475
Common stock issued for employee compensation		$ 4	28,568		28,572
Common stock issued for employee compensation (in shares)		3,572
Common shares issued for Directors fees		$ 7	44,993		45,000
Common shares issued for Directors fees (in shares)		7,325
Net loss				(8,424,440)	(8,424,440)
Balance at Jun. 30, 2019	$ 256	$ 3,845	102,712,845	(92,116,586)	10,600,360
Balance (in shares) at Jun. 30, 2019	255,714	3,844,921
Series A Preferred stock issued for employee stock compensation	$ 3		230,894		230,897
Series A Preferred stock issued for employee stock compensation (in shares)	2,888
Series A Preferred Stock issued for accounts payable-related party	$ 100		392,569		392,669
Series A Preferred Stock issued for accounts payable-related party (in Shares	100,000
Series A Preferred Stock issued for loan origination fee	$ 10		39,291		39,301
Series A Preferred Stock issued for loan origination fee (in shares)	10,000
Common stock issued for accounts payable		$ 8	51,992		52,000
Common stock issued for accounts payable (In shares)		8,467
Common stock issued in exchange for warrants		$ 677	5,721,866		5,722,543
Common stock issued in exchange for warrants (In shares)		677,224
Common stock issued upon cashless exercise of warrants		$ 180	1,153,701		1,153,881
Common stock issued upon cashless exercise of warrants (In shares)		180,087
Net proceeds from issuance of common stock in connection with equity financings		$ 4,275	16,672,700		16,676,975
Net proceeds from issuance of common stock in connection with equity financings (in shares)		4,275,000
Common stock issued for consulting and legal services rendered		$ 79	254,171		254,250
Common stock issued for consulting and legal services rendered (in shares)		78,958
Warrants issued to Scientific Advisory Board			7,373		7,373
Common stock issued for employee compensation		$ 4	29,247		29,251
Common stock issued for employee compensation (in shares)		3,572
Common shares issued for Directors fees		$ 11	44,985		45,000
Common shares issued for Directors fees (in shares)		10,728
Rounding - fractional shares		$ 4	(4)
Rounding - fractional shares (in shares)		4,457
Net loss				(13,446,538)	(13,446,538)
Balance at Jun. 30, 2020	$ 369	$ 9,083	$ 127,311,634	$ (105,563,124)	$ 21,757,962
Balance (in shares) at Jun. 30, 2020	368,602	9,083,414